Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CVR Medical Corp
CRRVF
Primary Symbol:
V.CVM.H
Healthcare
Medical Devices
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool...
, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CVM.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
XTRMNVSTR
X
View Profile
View Bullboard History
Comment by
XTRMNVSTR
on Jan 17, 2024 11:21am
RE:RE:RE:One year
I have tried to email but no response.
(2)
•••
Anthdino
X
View Profile
View Bullboard History
Comment by
Anthdino
on Jan 03, 2024 1:01am
RE:RE:One year
Where is Mr Bakema? Where is the person in charge? Anyone with information send as a message or make it public please .
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2%
posted May 28, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur's first international distribution agreement is over a three-year term with a company specializing in the sale of radiology products in Latin America. This initial agreement grants the distributor marketing and sales rights in two countries, for SmoothX 2%, a contrast medium for use in abdominal Computed Tomography (CT) diagnostic examinations. ...read more
(19)
•••
CheckingReality
X
View Profile
View Bullboard History
Comment by
CheckingReality
on Dec 29, 2023 1:06pm
RE:One year
I would have to agree about it probably never trading again. This stock has been destroyed by incompetence. Writing this off as a 100% capital loss.
(393)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Dec 21, 2023 1:17pm
One year
One year to the day since the last NR. Wonder how the Boys are progressing. LOL I guess the management is planning their Christmas (Holiday) party. Anyone here unvited? I doubt that this will ever
...more
(0)
•••
Roguey1
X
View Profile
View Bullboard History
Comment by
Roguey1
on Dec 14, 2023 1:18pm
RE:RE:Intellectual Property
Sad state of affairs. How long could they be listed on Tsx ? .....waiting for a miracle Merry Christmas to all.
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Nov 28, 2023 9:42am
RE:Intellectual Property
I would expect that CVR Medical could sell the IP as this would be a legitimate way to realise some value from the development of the device todate but I don't think they would get much for it as
...more
(0)
•••
Fizzgig64
X
View Profile
View Bullboard History
Post by
Fizzgig64
on Nov 24, 2023 1:57pm
Intellectual Property
Hi All, just curious if anyone knows if these fine folks at CVR can sell the intellectual property out from under us and never be heard from again? I've been expecting to see a similar
...more
(1)
•••
XTRMNVSTR
X
View Profile
View Bullboard History
Comment by
XTRMNVSTR
on Nov 16, 2023 5:55pm
RE:Helllllooooo
It would be nice to know what's going on, obviously not a lot but would be nice to hear from the company. I emailed and no response.
(2)
•••
Anthdino
X
View Profile
View Bullboard History
Post by
Anthdino
on Nov 15, 2023 5:39pm
Helllllooooo
Is anyone doing anything at cvr
(19)
•••
CheckingReality
X
View Profile
View Bullboard History
Post by
CheckingReality
on Nov 14, 2023 10:22am
Shame..
on management to destroy the potiential of a promising medical device. In the right hands this could already be used in hospitals and medical clinics.
(2)
•••
Anthdino
X
View Profile
View Bullboard History
Comment by
Anthdino
on Oct 18, 2023 10:58pm
RE:RE:RE:RE:RE:RE:RE:RE:CVR
This company is dead
(0)
•••
KHTX78130
X
View Profile
View Bullboard History
Comment by
KHTX78130
on Oct 16, 2023 10:22am
RE:RE:RE:RE:RE:RE:RE:CVR
FACTS!
(2)
•••
Anthdino
X
View Profile
View Bullboard History
Post by
Anthdino
on Oct 13, 2023 3:01pm
Warrents
Bright side here. Alot of warrants issued are expiring
(6)
•••
MineralQuest
X
View Profile
View Bullboard History
Comment by
MineralQuest
on Oct 11, 2023 10:25pm
RE:RE:RE:RE:RE:RE:CVR
If this were a medical waiting room we'd all be dead!!
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Oct 10, 2023 3:12pm
RE:RE:RE:RE:RE:CVR
Welcome to the 'waiting room' KHTX.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year